Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA/B NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemo-Radiotherapy in Locally Advanced Stage IIIA/B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (ETOP 6-14)
J Thorac Oncol 2020 Nov 11;[EPub Ahead of Print], S Peters, E Felip, U Dafni, A Tufman, M Guckenberger, R Álvarez, E Nadal, A Becker, H Vees, M Pless, A Martinez-Marti, M Lambrecht, N Andratschke, Z Tsourti, AC Piguet, H Roschitzki-Voser, A Gasca-Ruchti, J Vansteenkiste, RA Stahel, D RuysscherFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.